Philip Bejon
Director Modernising Medical Microbiology
I am Director of Modernising Medical Microbiology, co-leading with Sarah Walker. I was previously Director of the KEMRI-Wellcome Trust Research Programme, a collaborative Programme formed by the Kenya Medical Research Institute (KEMRI), Wellcome and University of Oxford. I am a clinician with specialist training in infectious disease. I have an interest in the evaluation of vaccines, including malaria, yellow fever and Ebola vaccines. I have undertaken studies of naturally acquired immunity to malaria and human challenge models, and have an interest in bone infection and osteomyelitis.
Recent publications
-
Nanopore adaptive sampling for bacterial identification from periprosthetic joint replacement tissue
Preprint
Street TL. et al, (2025)
-
Low-Dose Yellow Fever Vaccine in Adults in Africa
Journal article
Kimathi D. et al, (2025), New England Journal of Medicine, 392, 788 - 797
-
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
Journal article
Kimotho J. et al, (2024), Wellcome Open Research, 8, 350 - 350
-
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.
Journal article
Miotto O. et al, (2024), The Lancet. Microbe
-
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.
Journal article
Lucinde RK. et al, (2024), BMC infectious diseases, 24